In The Press
Lead Bioinformatician at the William Harvey Research Institute, Michael Barnes, co-authors study utilising Genome Wide Association Studies for repositioning drugs.
Sanseau et al. Nature Biotechnology 2012
Study of gene expression performed at the Centre shows detrimental effects of cigarette smoke on cell metabolism in monocytes.
Wright et al. PLoS One 2012

We are a constantly evolving genomics core facility. You can find out about our recent developments in services, bioinformatics, IT and management in our Spring Newsletter

Our Timeline. Founded in 2000 the Genome Centre at Barts and The London School of Medicine and Dentistry has successfully provided genetic and genomic research facilities to researchers within Queen Mary University and the wider Life Sciences research community for over 10 years

Initial investment in 2000 provided robotics, capillary sequencing and real-time PCR capability which we still support. Further investment in 2006 in microarray from Illumina (updated in 2011 to the iScan) enabled us to support high density SNP, Gene Expression and Methylation. 2008 and 2009 saw adoption of Illumina's next generation sequencing technology and the associated IT infrastructure. 2012 has seen us rolling out library preps using the Fluidigm and targeted sequencing on the MiSeq. With this portfolio of platforms the centre can facilitate, studies of the genome, transcriptome and epigenome on any scale.  

Our goal is to professionally partner all stages of your genetic or genomic research projects, including project proposal, experimental design, training, technical support, analysis and interpretation of data.